Clinical Trial Update: A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with SBRT in patients with stage IV renal cell cancer (AJCC 7th edition) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Stage IV Renal Cell Cancer AJCC V7 | Phase 2 | Status: COMPLETED